TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06150456

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extraction
Description: extraction: in all groups, extraction will be performed

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extraction
Description: extraction: in all groups, extraction will be performed

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extraction
Description: extraction: in all groups, extraction will be performed

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extraction
Description: extraction: in all groups, extraction will be performed

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: extraction: in all groups, extraction will be performed Treatment with low-intensity infrared 808 nm laser therapy will be applied in 2 stages: one in the immediate postoperative period and 10 days after surgery.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: extraction: in all groups, extraction will be performed Treatment with low-intensity infrared 808 nm laser therapy will be applied in 2 stages: one in the immediate postoperative period and 10 days after surgery.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Plenum® OSShp and Plenum® Guide
Description: extraction: in all groups, extraction will be performed Immediately after tooth extraction, the biomaterials Plenum® OSShp and Plenum® Guide (Brazil) will be added to the dental socket, serving as a bone substitute and maintaining alveolar dimensions.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Plenum® OSShp and Plenum® Guide
Description: extraction: in all groups, extraction will be performed Immediately after tooth extraction, the biomaterials Plenum® OSShp and Plenum® Guide (Brazil) will be added to the dental socket, serving as a bone substitute and maintaining alveolar dimensions.
Study: NCT05897268

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Cryoablation is performed under US or CT guidance per Investigator decision.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: a PD-1 immune check inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib capsules
Study: NCT04999033

Intervention type: OTHER
Intervention: no intervention
Description: This is a cross-sectional study, and no intervention will be included
Study: NCT04860596

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: collaborative health management model
Description: nursing education program
Study: NCT04841018

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose dexamethasone
Description: After caudal block with 1.2ml/kg of 0.15% ropivacaine, the patient receives 0.5mg/kg of intravenous dexamethasone
Study: NCT04712747

Intervention type: PROCEDURE
Intervention: Ophthalmological examinations
Description: * OCT (Optical Coherence Tomography): posterior pole OCT B scan , optic nerve and posterior pole OCT Angiography~* Adaptive optics (AO) : Image acquisition on the vessels at the exit of the optic nerve before the first upper temporal bifurcation OD or OG and evaluation of the photoreceptor mosaic. Adaptive optics may require dilatation of the pupil with a drop of tropicamide in the eye examined a few minutes before the examination.~* Color retinophotography~* Measurement of intraocular pressure~Patients with stroke : At the inclusion visit and 3 months after their stroke Control group : At the inclusion visit.

Intervention type: PROCEDURE
Intervention: Ophthalmological examinations
Description: * OCT (Optical Coherence Tomography): posterior pole OCT B scan , optic nerve and posterior pole OCT Angiography~* Adaptive optics (AO) : Image acquisition on the vessels at the exit of the optic nerve before the first upper temporal bifurcation OD or OG and evaluation of the photoreceptor mosaic. Adaptive optics may require dilatation of the pupil with a drop of tropicamide in the eye examined a few minutes before the examination.~* Color retinophotography~* Measurement of intraocular pressure~Patients with stroke : At the inclusion visit and 3 months after their stroke Control group : At the inclusion visit.
Study: NCT06342570

Intervention type: OTHER
Intervention: There is no Intervention name to describe.
Description: There is no Intervention name to describe.
Study: NCT04895098

Intervention type: DRUG
Intervention: statin and ezetimibe combination therapy
Description: Receiving statins (atorvastatin/rosuvastatin or others) in combination with ezetimibe 10mg/day in a stable dosing regimen (without changing the dose of the therapy and/or replacing the statin) for 3 or more months at the time of enrolment in the study.

Intervention type: DRUG
Intervention: statin monotherapy
Description: Receiving statins (atorvastatin/rosuvastatin or others) as monotherapy in a stable dosing regimen (without changing the dose of the therapy and/or replacing the statin) for 3 or more months at the time of enrolment in the study.
Study: NCT05822063

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine topical
Description: lidocaine spray

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cold packs
Description: ice packs

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: flash lights
Description: flash lights by camera
Study: NCT04841018

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose dexamethasone
Description: After caudal block with 1.2ml/kg of 0.15% ropivacaine, the patient receives 0.15mg/kg of intravenous dexamethasone
Study: NCT05370820

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: IV 2 minutes, IV 10 minutes, IM

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: IV 2 minutes, IV 10 minutes, IM

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: IV 2 minutes, IV 10 minutes, IM
Study: NCT05402982

Intervention type: DEVICE
Group type: OTHER
Intervention: Electrical Cardiometry (EC) ICON
Description: Electrical Cardiometry (EC) ICON (Osypka Medical, Berlin, Germany) is an FDA approved device used for non-invasive measurement of some hemodynamic parameters as cardiac output,cardiac index, stroke volume,stroke volume variation, systemic vascular resistance, thoracic fluid content, ICON (index of contractility), variation of ICON,corrected flow time and systolic time ratio.The set data of EC are the height, weight,hemoglobin, Oxygen saturation(SPO2),age, gender ,blood pressure and heart rate(HR) of the patient

Intervention type: OTHER
Group type: OTHER
Intervention: Rohrich formula
Description: Rohrich formula and the intraoperative fluid ratio (subcutaneous infiltration fluid plus intravenous fluid divided by total aspirate volume) will be 1.2
Study: NCT05236920

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device
Description: In-hospital use of a REBOA catheter device during advanced cardiac life support
Study: NCT05262036

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Anti-aging Supplement
Description: Mixture of different vitamins and nutrients

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Excipient powder
Study: NCT04838236

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MASP app + NRT
Description: MASP is a mobile intervention that targets anxiety sensitivity among African American smokers (Mobile Anxiety Sensitivity Program for Smoking: MASP). Our intervention is framed within the cultural context of interoceptive stress among African American smokers, which is supported by theory, empirical evidence, and characteristics of this group. The MASP app employs a variety of features to educate its users on how to deal with stress, anxiety, and nicotine withdrawal symptoms. The app contains a series of on-demand features, including a coping toolkit, stress management trainings, and a series of educational videos. MASP also utilizes Ecological Momentary Assessments (EMAs) to gather information, and provide personalized messages to users in real time.

Intervention type: OTHER
Group type: OTHER
Intervention: QuitGuide app + NRT
Description: Quitguide is a smartphone-based National Cancer Institute (NCI) app for standard mobile smoking cessation treatment. The app contains features that allows its' users to better understand their smoking patters, and build skills needed to becomes and stay smoke free. The app allows users to track their cravings, and delivers motivational messages to users for each craving they track.
Study: NCT05834530

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D Printed Complete Dentures
Description: Denture bases printed from a pre-polymerized block via additive technique, using photon S desktop 3D printer\* that relies on SLA technology and post cured by post curing unit.
Study: NCT05959434

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy + Relapse Prevention
Description: Cognitive-Behavioral Therapy that integrates Cognitive Processing Therapy for PTSD with Relapse Prevention for alcohol use disorder

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relapse Prevention
Description: Cognitive-Behavioral Therapy that targets alcohol use, specifically
Study: NCT05632341

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactococcus lactis
Description: 1 capsule once a day

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: maltodextrin
Description: 1 capsule once a day
Study: NCT05342415

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Internally Focused Exercise
Description: While performing the exercises participants will be instructed to focus on the muscle itself.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Externally Focused Exercise
Description: While performing the exercises participants will be instructed to focus on the external target (towel, target line, etc.)
Study: NCT05685901

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High polyphenolic olive oil. (Early harvest olive oil).
Description: High polyphenolic olive oil is normal olive oil obtained from early harvest olives, this early harvest olive oil has been widely used for culinary purposes for centuries. The investigators wanted to study if oromucosal immunoprophylaxis with small quantities of high polyphenolic olive oil (2 mL of olive oil equivalent to 5 mg of polyphenols) adiministered twice a day could have clinical mitigating effects on the disease caused by SARS-CoV-2 infection.The primary outcome was to determine the effect of high polyphenolic olive oil on Coronavirus disease incidence, duration and severity.
Study: NCT05200962

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: In tDCS, direct electrical currents are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm).

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: In tDCS, direct electrical currents are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm).
Study: NCT05291832

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain.fm Music
Description: Experimental arm
Study: NCT04712747

Intervention type: PROCEDURE
Intervention: Blood pressure measurement at rest
Description: At the inclusion visit

Intervention type: PROCEDURE
Intervention: Blood pressure measurement at rest
Description: At the inclusion visit
Study: NCT05057182

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2
Description: BNT162b2 mRNA vaccine (Cominarty®, BioNTech/Fosun Pharma), one dose (0.3mL after dilution) contains 30 micrograms of COVID-19 mRNA Vaccine embedded in lipid nanoparticles.
Study: NCT05291832

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spectrally-matched Noise
Description: Active control arm
Study: NCT05147038

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tele-coaching
Description: The participants are instructed to use a Fitbit fitness tracker to record the number of steps. This device is compatible with the m-PAC App, which was developed for this specific group of participants (individuals suffering from a chronic lung disease). The participants receive a feedback via the m-PAC App every day and they also receive a week report to be albe to adjust their step goal. They are asked to increase or keep their week goal every Sunday after reviewing a weekly report. The participants also receive tips for their PA improvement and they are asked for medication change specification (every Wednesday).
Study: NCT05007665

Intervention type: BIOLOGICAL
Intervention: SARS-COV-2 VACCINE
Description: the antibody titer and adverse reactions were observed.
Study: NCT04887233

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Longan nasal spray
Description: The patients will be received 2 puff of Longan nasal spray 2 times/day for 3 days.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The patients will be received 2 puff of placebo nasal spray 2 times/day for 3 days.
Study: NCT04977063

Intervention type: DEVICE
Group type: OTHER
Intervention: Atmo gas capsule
Description: The Atmo Gas Capsule measures the capsules location and motility/transit times through gas sensing capabilities

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill
Description: The SmartPill measures the capsules location and motility/transit times through pH sensing
Study: NCT05132478

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotionally Supportive Video
Description: The video is approximately 6 1/2 minutes in length and portrays an emotionally supportive conversation between a patient and surgeon during which the surgeon discusses: the diagnosis, prognosis, available treatment options, benefits and harms of the options, and need for decision making. The surgeon speaks for the majority of the simulated visit and discusses total and hemi-thyroidectomy with the addition of emotionally supportive statements and gestures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Video
Description: The video is approximately 5 minutes in length and portrays a standard conversation between a patient and surgeon during which the surgeon discusses: the diagnosis, prognosis, available treatment options, benefits and harms of the options, and need for decision making. The surgeon speaks for the majority of the simulated visit and discusses total and hemi-thyroidectomy.
Study: NCT05839535

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BDJ
Description: BDJ is a mind-body intervention

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BDJ
Description: BDJ is a mind-body intervention

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: tDCS is a brain stimulation method.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: tDCS is a brain stimulation method.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham tDCS
Description: sham tDCS

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham tDCS
Description: sham tDCS

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: exercise including stretching and other activities.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: exercise including stretching and other activities.
Study: NCT04326192

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Research electrode
Description: A second electrode will be placed percutaneously by Tuohy needle in the epidural space at the same time as the SCS trial implant; at lateral T1-2 area randomly assigned to the left or right side of the lateral epidural space, at the time of the procedure. Placement of electrodes is not experimental, but the placement of a second electrode is a research-driven procedure.
Study: NCT05397548

Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of levels of circulating exosomal lncRNA-GC1
Description: Each participant was enrolled to assess the levels of circulating exosomal lncRNA-GC1

Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of levels of circulating exosomal lncRNA-GC1
Description: Each participant was enrolled to assess the levels of circulating exosomal lncRNA-GC1
Study: NCT05369169

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resonance breathing
Description: Participants will synchronize their breathing with a visual pacer (E-Z Air, Thought Technology, Ltd., Plattsburgh, NY) that moves up (inhale) and down (exhale) at the rate of 0.1 Hz (6 breaths per min)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low demand cognitive task
Description: Different colored rectangles are presented for 10 sec each, and participants are instructed to silently count the number of blue rectangles
Study: NCT04597658

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bodyweight supported treadmill training (BWSTT)
Description: In the BWSTT group, walking training will be given by asking the patients to walk on the treadmill as fast as they can, without exceeding the medium intensity according to the Borg scale. Bodyweight support will be gradually reduced according to the patient's tolerance.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: The conventional rehabilitation program includes posture and breathing exercises, lower extremity stretching, active-assistive range of motion and strengthening, balance-coordination exercises, and walking with a physiotherapist on a smooth surface.
Study: NCT05881317

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArtiAid® Plus Intra-articular Injection
Description: Inject ArtiAid® Plus in the affected joint at weekly interval for 3 weeks
Study: NCT06498336

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory examination to determine the presence of sepsis
Description: Standard laboratory biochemical methods will be used to determine sepsis diagnosis accord-ing to SEPSIS 3 (1). Blood samples for obtaining serum/plasma of the patients will be taken on the 1st and 4th day of sepsis diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory examination to determine the presence of sepsis and acute kidney injury
Description: Standard laboratory biochemical methods will be used to determine sepsis diagnosis according to SEPSIS 3 and acute kidney injury according to Guidelines Kidney Disease Improving Global Outcomes (KDIGO) 2012 (2). Blood samples for obtaining serum/plasma of the patients will be taken on the 1st and 4th day of sepsis diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory examination to determine miRNA and biochemical parameters
Description: Laboratory examination will be performed to determine miRNA and biochemical parameters.
Study: NCT06152939

Intervention type: OTHER
Intervention: Primary percutaneous coronary intervention or thrombolytic therapy
Description: Primary percutaneous coronary intervention or thrombolytic therapy

Intervention type: OTHER
Intervention: Primary percutaneous coronary intervention or thrombolytic therapy
Description: Primary percutaneous coronary intervention or thrombolytic therapy
Study: NCT06451913

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin + Saccharomyces boulardii CNCM I-745
Description: At inclusion visit (V1), the Investigator will dispense and ask the subject to take Amoxicillin 1000 mg bid for 14 days + Saccharomyces boulardii 250 mg x 2 twice a day for 21 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amoxicillin + Placebo
Description: At inclusion visit (V1),the Investigator will dispense and ask the subject to take Amoxicillin 1000 mg bid for 14 days + a matching placebo bid for 21 days

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Stool samples
Description: The subject will be asked to collect thanks to four OMNIgene® •GUT OMR-200 kits :~* an initial stool collection when returning home at D1 (in any case before any intake of amoxicillin and of the investigational medication and up to 1 day after D1).~* a stool collection at home after the phone call 1, Day 7 (stool collection up to Day 7 + 1 day)~* a stool collection at home after the phone call 2, Day 14 (stool collection up to Day 14 + 1 day)~* at home the day of the Visit 2, Day 21 (stool collection up to Day 21 + 1 day)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stool samples
Description: The subject will be asked to collect thanks to four OMNIgene® •GUT OMR-200 kits :~* an initial stool collection when returning home at D1 (in any case before any intake of amoxicillin and of the investigational medication and up to 1 day after D1).~* a stool collection at home after the phone call 1, Day 7 (stool collection up to Day 7 + 1 day)~* a stool collection at home after the phone call 2, Day 14 (stool collection up to Day 14 + 1 day)~* at home the day of the Visit 2, Day 21 (stool collection up to Day 21 + 1 day)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: BSFS : Bristol Stool Form Scale
Description: All included subjects will have to complete a stool diary BSFS (Bristol Stool Form Scale) daily and at each bowel movement, from Day 1 until the end of study treatment (Day 21). The patient will fill the form with the date, the time, and the stool texture.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BSFS : Bristol Stool Form Scale
Description: All included subjects will have to complete a stool diary BSFS (Bristol Stool Form Scale) daily and at each bowel movement, from Day 1 until the end of study treatment (Day 21). The patient will fill the form with the date, the time, and the stool texture.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: GSRS : Gastrointestinal Symptom Rating Scale
Description: All included subjects will have to complete a GSRS (Gastrointestinal Symptom Response Score) questionnaire weekly from Day 1 until the end of the study treatment (Day 21).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GSRS : Gastrointestinal Symptom Rating Scale
Description: All included subjects will have to complete a GSRS (Gastrointestinal Symptom Response Score) questionnaire weekly from Day 1 until the end of the study treatment (Day 21).
Study: NCT05765019

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal mobilization
Description: Spinal mobilization and core stabilization exercise

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stabilization exercise
Description: Stabilization exercises for the spine

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise
Description: Stabilization exercises for the spine